We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$2.54B
(+14%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
7.41%
Top 10 Holdings %
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$798M |
| 2 |
ExxonMobil
XOM
|
+$189M |
| 3 |
Cognizant
CTSH
|
+$86.4M |
| 4 |
Merck
MRK
|
+$80.6M |
| 5 |
Integra LifeSciences
IART
|
+$47.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$57.5M |
| 2 |
PepsiCo
PEP
|
+$55.1M |
| 3 |
Dollar General
DG
|
+$49.7M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$48.1M |
| 5 |
Simon Property Group
SPG
|
+$45.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.52% |
| 2 | Technology | 14.11% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Wabtec
WAB
$51.1B
| $510K | ﹤0.01% |
6,553
-107
| -2% | -$8.83K |
|
|
EVHC
852
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $507K | ﹤0.01% |
8,279
-591
| -7% | -$39.6K |
|
853
Steris
STE
$20.9B
| $504K | ﹤0.01% |
7,273
+882
| +14% | +$61K |
|
|
TVPT
854
DELISTED
Travelport Worldwide Limited
TVPT
| $502K | ﹤0.01% |
42,681
+5,725
| +15% | +$76.1K |
|
855
Atkore
ATKR
$2.59B
| $498K | ﹤0.01% |
+18,970
| New | +$488K |
|
|
POLY
856
DELISTED
Plantronics, Inc.
POLY
| $490K | ﹤0.01% |
9,075
-2,927
| -24% | -$159K |
|
857
W.R. Berkley
WRB
$28B
| $482K | ﹤0.01% |
23,072
+4,486
| +24% | +$92.3K |
|
|
VSM
858
DELISTED
Versum Materials, Inc.
VSM
| $482K | ﹤0.01% |
15,792
-3,987
| -20% | -$116K |
|
859
Manhattan Associates
MANH
$8.97B
| $481K | ﹤0.01% |
9,285
-1,644
| -15% | -$82.9K |
|
860
RB Global
RBA
$20.8B
| $480K | ﹤0.01% |
14,600
-1,700
| -10% | -$55.1K |
|
861
Avnet
AVT
$7.33B
| $475K | ﹤0.01% |
10,394
+2,084
| +25% | +$96.4K |
|
862
Sumitomo Mitsui Financial
SMFG
$166B
| $475K | ﹤0.01% |
65,699
-35,310
| -35% | -$274K |
|
|
NSR
863
DELISTED
Neustar Inc
NSR
| $475K | ﹤0.01% |
14,351
-12,358
| -46% | -$411K |
|
864
ING
ING
$93.8B
| $473K | ﹤0.01% |
31,408
-23,976
| -43% | -$351K |
|
865
Plexus
PLXS
$6.81B
| $469K | ﹤0.01% |
8,126
| – | – |
|
|
DNB
866
DELISTED
Dun & Bradstreet
DNB
| $465K | ﹤0.01% |
4,314
| – | – |
|
867
Revvity
RVTY
$12.3B
| $464K | ﹤0.01% |
8,002
-45,331
| -85% | -$2.47M |
|
868
Insperity
NSP
$1.85B
| $462K | ﹤0.01% |
10,444
-3,966
| -28% | -$158K |
|
869
Annaly Capital Management
NLY
$16.9B
| $459K | ﹤0.01% |
10,363
+1,325
| +15% | +$56.4K |
|
870
MillerKnoll
MLKN
$1.5B
| $457K | ﹤0.01% |
14,541
+2,841
| +24% | +$87.9K |
|
|
NBLX
871
DELISTED
Noble Midstream Partners LP
NBLX
| $456K | ﹤0.01% |
8,761
+1,944
| +29% | +$89.3K |
|
872
AMERISAFE
AMSF
$569M
| $449K | ﹤0.01% |
6,928
-2,384
| -26% | -$153K |
|
873
Steel Dynamics
STLD
$35.6B
| $449K | ﹤0.01% |
12,933
+633
| +5% | +$22.6K |
|
|
ONCE
874
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $442K | ﹤0.01% |
8,302
| – | – |
|
875
Lincoln Electric
LECO
$13.8B
| $441K | ﹤0.01% |
5,088
+394
| +8% | +$33.1K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2017 Portfolio in Review
As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.
- Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
- Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
- Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
- Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
- Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
- Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
- Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.
Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.